Plasma levels of miR-21b and miR-146a can discriminate rheumatoid arthritis diagnosis and severity.

ABSTRACT:

Objectives

This study tried to examine the ability of the estimated plasma gene-expression levels (PGEL) of microRNA (miR)-146a and miR-21b to distinguish patients with early rheumatoid arthritis (RA) out of arthritis patients who did not fulfill the diagnostic spectrum of either RA or osteoarthritis (OA); the diagnostic Gray-Zone (GZ).

Patients & methods

Enrolled patients underwent full diagnostic workup and were categorized as highseropositive and fulfilled the diagnostic spectrum for RA (RA-group), seronegative and fulfilling the diagnostic spectrum of OA (OA-group) and low-seropositive or seronegative patients who did not fulfill diagnostic criteria of RA or OA (GZ-group). Blood samples were obtained for quantification of PGEL of miR-146a and miR-21-b using the quantitat

SUBMITTER: Sarhan RS 

PROVIDER: S-EPMC11959981 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature